Philip Beachy Ph.D.

'Fate Therapeutics' founders include researchers from across the United States.
— Philip Beachy, Ph.D., Stanford University Institute for Stem Cell Biology and Regenerative Medicine and HHMI has pioneered the use of synthetic small molecules and natural products to manipulate activities of developmental and stem cell signaling pathways in vitro and in vivo. Click to read the complete article.December 8th, 2007 Posted by: myambutol.